← All Topics / ade

FDA ADE reports for Bupivicaine

ade_bupivicaine_adverse_events

ade en 2026-07-22

Bupivicaine — FDA Animal & Veterinary Adverse Event (ADE) Reports

Source: openFDA animalandveterinary/event.json, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-22. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. Bupivicaine is a active ingredient.

Total reports

Bupivicaine: 39

Reports by species (top entries)

  • Dog 24
  • Cat 15

Top reported reactions (VEDDRA terms, top entries)

  • Death 7
  • Elevated alanine aminotransferase (ALT) 6
  • Hyperphosphataemia 6
  • Other abnormal test result NOS 6
  • Elevated creatinine 5
  • Fever 5
  • Not eating 5
  • Vomiting 5
  • Ataxia 4
  • Death by euthanasia 4

Source JSON: pdf-raw/ade/ade_active_ingredients_2026-07-22_b28.json (openFDA animalandveterinary/event.json, pulled 2026-07-22).

Sources

FDA ADE reports for Bupivicaine (active ingredient) — total reports, species & reaction breakdown
Source document: FDA FAERS / openFDA Animal & Veterinary Event Reports
US FDA Center for Veterinary Medicine (openFDA animal & veterinary event database)retrieved 2026-07-22

Verification file: pdf-raw/ade/ade_active_ingredients_2026-07-22_b28.json

Link points to the issuing authority's site; a direct document link is still being verified.